Your GLP-1 PSP is leaking millions.
Select your care setting below for a tailored look at how FriskaAi fits your workflow, your patients, and your outcomes goals.
The Real Cost of Poor Persistence:
High dropout rate
35–42% within 12 months
Millions lost in revenue
Recurring revenue disappears
Suboptimal outcomes
Limited sustained results
Ineffective support
Lacks personalized guidance
Your GLP-1 PSP is leaking millions.
Friska Ai is the white-labelled persistence engine that dramatically boosts patient persistence and unlocks significant recurring revenue with zero disruption.
The Real Cost of Poor Persistence:
High dropout rate
35–42% within 12 months
Millions lost in revenue
Recurring revenue disappears
Suboptimal outcomes
Limited sustained results
Ineffective support
Lacks personalized guidance
A meaningful improvement in persistence unlocks significant recurring revenue per patient population.
THE PROBLEM
The revenue leak nobody talks about.
Your PSP is built to onboard patients. It was never designed to keep them on therapy long‑term.
The result? Predictable, preventable revenue leakage of 35–42% within 12 months.
Typically 58–65% persistence at 1 year
Current PSP baseline (typical GLP‑1 PSP baseline)
Often 35–42% patient drop-off
Patient drop‑off = direct, preventable revenue loss
Approximately $525 per extra month retained
per extra month retained = real revenue impact per patient
This isn’t a clinical problem. It’s a missing layer in your revenue architeture.
THE PROBLEM
The revenue leak nobody talks about.
Your PSP is built to onboard patients. It was never designed to keep them on therapy long‑term.
The result? Predictable, preventable revenue leakage of 35–42% within 12 months.
Typically 58–65% persistence at 1 year
Current PSP baseline (typical GLP‑1 PSP baseline)
Often 35–42% patient drop-off
Patient drop‑off = direct, preventable revenue loss
Approximately $525 per extra month retained
per extra month retained = real revenue impact per patient
This isn’t a clinical problem. It’s a missing layer in your revenue architeture.
Why current PSPs plateau
Built for onboarding, not adherence.
PSPs excel at enrollment and initial support. They lack the daily behavioral layer needed to sustain long-term adherence.
No real-time guidance.
Patients face side effects, titration challenges, and motivation dips between visits. Without daily support, they drop off.
Invisible to your team.
PSP Teams lack real-time visibility into patient adherence and early warning signs of drop-off.
THE SOLUTION
Meet FriskaAi: The persistence engine
Friska embeds directly into your PSP as a white-labeled persistence layer. It’s not a standalone app. It’s the missing daily adherence infrastructure your PSP needs.
Daily AI-driven engagement
Personalized nutrition, side-effect guidance, and behavioral reinforcement.
Real-time adherence tracking
Your PSP team gets visibility into patient adherence and early warning signs.
Zero patient friction
Seamlessly embedded. No new apps. No additional workflows.
Enterprise-grade security
HIPAA compliant, EMR integrated, white-labeled.
PSP platform
EHR data
Device data
Patient reports
FriskaAi
Persistence engine
Data integration
AI analytics
Rules & workflow
Patient outcomes
Personalized insights
Adherence tracking
Health improvements
The result: Patients stay on therapy longer. Your PSP captures the recurring revenue already in your patient population.
Benchmarked results
15-25%
Persistence improvement
From comparable programs
2.2 x
Longer time on therapy
From comparable programs
70% +
Patient engagement
From comparable programs
3x
Higher 20%+ weight loss
From comparable programs
Results are benchmarked from comparable AI-supported PSP and adherence programs and are not direct FriskaAi trial data.
Calculate your ROI potential
See exactly how much recurring revenue FriskaAi can help you capture from your existing GLP-1 patient population.
Number of patients
10,00,000
Quick select
$630M
20% Uplift
$472M
15% Uplift
$315M
10% Uplift
Deployment: Zero disruption
Pilot cohort
Identify a patient cohort and run a 90-day pilot. No organization disruption.
Seamless integration
Friska embeds into your existing PSP infrastructure. No new systems. No patient friction.
Scale across portfolio
Proven results? Roll out across your GLP-1 patient population. Capture billions.
Frequently asked questions
How do we get started?
Simply book a demo. We’ll show you how FriskaAi integrates with your PSP, run a personalized revenue impact analysis, and help you set up a pilot.
How does FriskaAi integrate with your current PSP?
FriskaAi is designed for zero disruption. It seamlessly connects with your existing PSP platform, EHR data, device data, and patient reports. It works as an embedded module no new systems, no new workflows, and no changes to your current infrastructure.
Do patients need to download a new app?
No. Patients do not need to download anything new. FriskaAi delivers support through the same channels your PSP already uses (SMS, patient portal, email, or in-app messages), creating zero additional friction.
What kind of messages will patients actually receive?
Patients receive:
- Personalized nutrition guidance
- Real-time side-effect management (e.g., nausea tips)
- Habit-building reminders (hydration, streaks, etc.)
Is FriskaAi secure and HIPAA compliant?
Yes. FriskaAi is fully HIPAA compliant, enterprise-grade secure, and built with EMR integration in mind. Patient data privacy and security are our top priority.
Ready to stop the leak and capture your full GLP‑1 revenue?
The opportunity to unlock hundreds of millions in recurring revenue is immediate. Let’s discuss how FriskaAi can integrate seamlessly with your PSP.
Verify your email to continue booking the demo
We'll send a quick verification code
Email verification successful
Every patient. Every visit. Every day in between.
2026 © All Rights Reserved by FriskaAi
Follow us on:
